Nonstroke Cardiovascular Disease and Risk of Alzheimer Disease and Dementia

被引:42
作者
Eriksson, Ulrika K. [1 ]
Bennet, Anna M. [1 ]
Gatz, Margaret [1 ,2 ]
Dickman, Paul W. [1 ]
Pedersen, Nancy L. [1 ,2 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm 17177, Sweden
[2] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA
基金
美国国家卫生研究院; 瑞典研究理事会;
关键词
Alzheimer disease; cardiovascular disease; risk factor; ApoE; longitudinal; co-twin control; APOLIPOPROTEIN-E; COGNITIVE-ABILITIES; VASCULAR DEMENTIA; ATHEROSCLEROSIS; ASSOCIATION; HEALTH; SEX; NEUROPATHOLOGY; DIAGNOSIS; CRITERIA;
D O I
10.1097/WAD.0b013e3181d1b99b
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Unresolved issues in dementia research include (1) the association between nonstroke cardiovascular disease (CVD) and Alzheimer disease (AD) and (2) whether the association between CVD and dementia is mediated by familial factors (ie, genes and early life environment). We therefore conducted a study with both a longitudinal and a co-twin control design in 2214 Swedish twins with clinical dementia evaluation and apolipoprotein E (ApoE) genotyping. The analyses were then replicated in a register-based cohort of 18,405 individuals. Results show that CVD increases the risk of AD in carriers (but not noncarriers) of the ApoE4 allele (hazard ratio 2.39, 95% confidence interval 1.15-4.96). CVD was also associated with an almost 2-fold increased risk of developing late-life dementia (hazard ratio 1.83, 95% confidence interval 1.23-2.72). Within twin pairs, the dementia-affected twin was more likely to have had CVD than the nondemented twin partner (odds ratio 1.86, 95% confidence interval 1.11-3.13). In conclusion, this study shows that (1) nonstroke CVD increases the risk of late-life dementia but that it is only a risk factor for AD in carriers of the ApoE4 allele and (2) the association between CVD and dementia is not explained by genetic or early life environmental factors in common to both disorders.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 41 条
[1]   Rethinking the dementia diagnoses in a population-based study:: What is Alzheimer's disease and what is vascular dementia?: A study from the Kungsholmen project [J].
Agueero-Torres, Hedda ;
Kivipelto, Miia ;
von Strauss, Eva .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 22 (03) :244-249
[2]  
[Anonymous], 2000, VARD DIAGN AK HJART
[3]   Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida Brain Bank [J].
Barker, WW ;
Luis, CA ;
Kashuba, A ;
Luis, M ;
Harwood, DG ;
Loewenstein, D ;
Waters, C ;
Jimison, P ;
Shepherd, E ;
Sevush, S ;
Graff-Radford, N ;
Newland, D ;
Todd, M ;
Miller, B ;
Gold, M ;
Heilman, K ;
Doty, L ;
Goodman, I ;
Robinson, B ;
Pearl, G ;
Dickson, D ;
Duara, R .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (04) :203-212
[4]   Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers [J].
Beeri, MS ;
Rapp, M ;
Silverman, JM ;
Schmeidler, J ;
Grossman, HT ;
Fallon, JT ;
Purohit, DP ;
Perl, DP ;
Siddiqui, A ;
Lesser, G ;
Rosendorff, C ;
Haroutunian, V .
NEUROLOGY, 2006, 66 (09) :1399-1404
[5]   Association of apolipoprotein E genotypes with lipid levels and coronary risk [J].
Bennet, Anna M. ;
Di Angelantonio, Emanuele ;
Ye, Zheng ;
Wensley, Frances ;
Dahlin, Anette ;
Ahlbom, Anders ;
Keavney, Bernard ;
Collins, Rory ;
Wiman, Bjoern ;
de Faire, Ulf ;
Danesh, John .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (11) :1300-1311
[6]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[7]   CARDIOVASCULAR-DISEASE AND DISTRIBUTION OF COGNITIVE FUNCTION IN ELDERLY PEOPLE - THE ROTTERDAM STUDY [J].
BRETELER, MMB ;
CLAUS, JJ ;
GROBBEE, DE ;
HOFMAN, A .
BRITISH MEDICAL JOURNAL, 1994, 308 (6944) :1604-1608
[8]  
Carstensen B., LEXIS SAS MACRO
[9]   Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins [J].
Casserly, I ;
Topol, E .
LANCET, 2004, 363 (9415) :1139-1146
[10]   Cognitive impact of subcortical vascular and Alzheimer's disease pathology [J].
Chui, Helena C. ;
Zarow, Chris ;
Mack, Wendy J. ;
Ellis, William G. ;
Zheng, Ling ;
Jagust, William J. ;
Mungas, Dan ;
Reed, Bruce R. ;
Kramer, Joel H. ;
DeCarli, Charles C. ;
Weiner, Michael W. ;
Vinters, Harry V. .
ANNALS OF NEUROLOGY, 2006, 60 (06) :677-687